Lake Point Wealth Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Lake Point Wealth Management’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200	Closed	–	–	505
2021 Q4	$0	Hold	200	–	–	﹤0.01%	505
2021 Q3	$1K	Hold	200	–	–	﹤0.01%	398
2021 Q2	$1K	Buy	+200	New	+$687	﹤0.01%	406

Other funds holding ODT

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Lake Point Wealth Management's ODT Position: Q1 2022 in Review

Lake Point Wealth Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 200 shares.

Lake Point Wealth Management first reported a position in ODT in Q2 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

Lake Point Wealth Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Lake Point Wealth Management sold 200 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022.
Lake Point Wealth Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Lake Point Wealth Management's Odonate Therapeutics, Inc. Common Stock position peaked at $1K in Q3 2021.
8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Lake Point Wealth Management's 13F filing for Q1 2022, filed 17 May 2022.